4.8 Article

High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity

Journal

NATURE BIOTECHNOLOGY
Volume 31, Issue 9, Pages 839-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nbt.2673

Keywords

-

Funding

  1. DARPA [HR0011-11-2-0003, N66001-12-C-4207]
  2. Howard Hughes Medical Institute
  3. National Institute of General Medical Sciences [T32GM007753]
  4. Howard Hughes Medical Institute (HHMI)
  5. US National Institutes of Health [R01GM073794-05]
  6. HHMI

Ask authors/readers for more resources

The RNA-programmable Cas9 endonuclease cleaves double-stranded DNA at sites complementary to a 20-base-pair guide RNA. The Cas9 system has been used to modify genomes in multiple cells and organisms, demonstrating its potential as a facile genome-engineering tool. We used in vitro selection and high-throughput sequencing to determine the propensity of eight guide-RNA:Cas9 complexes to cleave each of 10(12) potential off-target DNA sequences. The selection results predicted five off-target sites in the human genome that were confirmed to undergo genome cleavage in HEK293T cells upon expression of one of two guide-RNA:Cas9 complexes. In contrast to previous models, our results show that guide-RNA:Cas9 specificity extends past a 7- to 12-base-pair seed sequence. Our results also suggest a tradeoff between activity and specificity both in vitro and in cells as a shorter, less-active guide RNA is more specific than a longer, more-active guide RNA. High concentrations of guide-RNA:Cas9 complexes can cleave off-target sites containing mutations near or within the PAM that are not cleaved when enzyme concentrations are limiting.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available